AU2399300A - Methods and compositions for inhibiting neoplastic cell growth - Google Patents

Methods and compositions for inhibiting neoplastic cell growth

Info

Publication number
AU2399300A
AU2399300A AU23993/00A AU2399300A AU2399300A AU 2399300 A AU2399300 A AU 2399300A AU 23993/00 A AU23993/00 A AU 23993/00A AU 2399300 A AU2399300 A AU 2399300A AU 2399300 A AU2399300 A AU 2399300A
Authority
AU
Australia
Prior art keywords
compositions
methods
cell growth
neoplastic cell
inhibiting neoplastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23993/00A
Inventor
Avi J. Ashkenazi
Kevin P. Baker
Audrey Goddard
Austin L. Gurney
Mary A. Napier
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/005028 external-priority patent/WO1999046281A2/en
Priority claimed from PCT/US1999/020594 external-priority patent/WO2000015666A2/en
Priority claimed from PCT/US1999/030999 external-priority patent/WO2001005836A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2399300A publication Critical patent/AU2399300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU23993/00A 1999-03-08 1999-12-30 Methods and compositions for inhibiting neoplastic cell growth Abandoned AU2399300A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
WOUS9905028 1999-03-08
PCT/US1999/005028 WO1999046281A2 (en) 1998-03-10 1999-03-08 Novel polypeptides and nucleic acids encoding the same
US12677399P 1999-03-29 1999-03-29
US60126773 1999-03-29
US14475899P 1999-07-20 1999-07-20
US60144758 1999-07-20
WOUS9920594 1999-09-08
PCT/US1999/020594 WO2000015666A2 (en) 1998-09-10 1999-09-08 Compositions and methods for the treatment of tumors
WOUS9930999 1999-12-20
PCT/US1999/030999 WO2001005836A1 (en) 1999-07-20 1999-12-20 Polypeptidic compositions and methods for the treatment of tumors
PCT/US1999/031243 WO2000053751A1 (en) 1999-03-08 1999-12-30 Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number Publication Date
AU2399300A true AU2399300A (en) 2000-09-28

Family

ID=56289985

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23993/00A Abandoned AU2399300A (en) 1999-03-08 1999-12-30 Methods and compositions for inhibiting neoplastic cell growth

Country Status (2)

Country Link
AU (1) AU2399300A (en)
WO (1) WO2000053751A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002532054A (en) 1997-08-29 2002-10-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 29 human secreted proteins
EP1309620A2 (en) * 2000-06-23 2003-05-14 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
CA2416538A1 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
DE69837761T2 (en) * 1997-08-01 2008-01-17 Serono Genetics Institute S.A. 5 'ESTS FOR SECRETED PROTEINS FROM BRAIN TISSUE
JP2002532054A (en) * 1997-08-29 2002-10-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 29 human secreted proteins
US5968744A (en) * 1997-10-14 1999-10-19 Incyte Pharmaceticals, Inc. Human cornichon molecule
ES2312205T3 (en) * 1998-03-10 2009-02-16 Genentech, Inc. NEW POLYPEPTIDE AND NUCLEIC ACIDS THAT CODE IT.

Also Published As

Publication number Publication date
WO2000053751A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU3652499A (en) Iol for inhibiting cell growth and reducing glare
IL140686A0 (en) Compositions and methods for inhibiting fungal growth
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU5170900A (en) Cell proliferation inhibitors
AU5994900A (en) Compounds for inhibiting diseases and preparing cells for transplantation
AU5991699A (en) Quinolizinones as integrin inhibitors
AU3246100A (en) Methods and compositions for inhibiting neoplastic cell growth
AU2001233502A1 (en) Pancreatic islet cell growth factors
AU2832399A (en) B cell inhibitors
AU3235100A (en) Prothease inhibitors
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2215300A (en) Methods and compositions for inhibiting neoplastic cell growth
AU2399300A (en) Methods and compositions for inhibiting neoplastic cell growth
AU4849199A (en) Fungal growth inhibitors
AU6859500A (en) Plant gene
AU1389801A (en) Modification of plants
AU1749800A (en) Methods and compositions for inhibiting neoplastic cell growth
AU6006800A (en) Treating cells
AU5640200A (en) Gene affecting male fertility in plants
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use
AU5591100A (en) Methods and compositions for inhibiting neoplastic cell growth
IL147148A0 (en) Epithelial cell growth inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase